loadpatents
name:-0.011954069137573
name:-0.01120400428772
name:-0.013514995574951
Nuijens; Timo Patent Filings

Nuijens; Timo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nuijens; Timo.The latest application filed is for "chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1".

Company Profile
11.11.11
  • Nuijens; Timo - Geleen NL
  • Nuijens; Timo - Valkenburg NL
  • Nuijens; Timo - Maastricht N/A NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chemo-enzymatic synthesis of semaglutide, liraglutide and GLP-1
Grant 10,920,258 - Nuijens , et al. February 16, 2
2021-02-16
Chemo-enzymatic synthesis of Semaglutide, Liraglutide and GLP-1
Grant 10,883,132 - Nuijens , et al. January 5, 2
2021-01-05
Chemo-enzymatic synthesis of semaglutide, liraglutide and GLP-1
Grant 10,858,414 - Nuijens , et al. December 8, 2
2020-12-08
Chemo-enzymatic Synthesis Of Semaglutide, Liraglutide And Glp-1
App 20200347427 - NUIJENS; Timo ;   et al.
2020-11-05
Designing an enzymatic peptide fragment condensation strategy
Grant 10,752,931 - Nuijens , et al. A
2020-08-25
Chemo-enzymatic Synthesis Of Semaglutide, Liraglutide And Glp-1
App 20200262886 - NUIJENS; Timo ;   et al.
2020-08-20
Chemo-enzymatic Synthesis Of Semaglutide, Liraglutide And Glp-1
App 20190345529 - NUIJENS; Timo ;   et al.
2019-11-14
Subtilisin variants having a mutation in the S2 or S2# pocket
Grant 10,336,994 - Toplak , et al.
2019-07-02
Peptide fragment condensation and cyclisation using a subtilisin variant with improved synthesis over hydrolysis ratio
Grant 10,253,061 - Quaedflieg , et al.
2019-04-09
Subtilisin Variants Having A Mutation In The S2 Or S2' Pocket
App 20190078069 - Toplak; Ana ;   et al.
2019-03-14
Peptide Fragment Condensation And Cyclisation Using A Subtilisin Variant With Improved Synthesis Over Hydrolysis Ratio
App 20190031710 - QUAEDFLIEG; Peter Jan Leonard Mario ;   et al.
2019-01-31
Peptide fragment condensation and cyclisation using a subtilisin variant with improved synthesis over hydrolysis ratio
Grant 10,138,268 - Quaedflieg , et al. Nov
2018-11-27
Designing An Enzymatic Peptide Fragment Condensation Strategy
App 20180187231 - Nuijens; Timo ;   et al.
2018-07-05
Peptide Fragment Condensation And Cyclisation Using A Subtilisin Variant With Improved Synthesis Over Hydrolysis Ratio
App 20170305963 - QUAEDFLIEG; Peter Jan Leonard Mario ;   et al.
2017-10-26
Side-chain Protected Oligopeptide Fragment Condensation Using Subtilisins In Organic Solvents
App 20150037840 - Quaedflieg; Peter Jan Leonard Mario ;   et al.
2015-02-05
Peptide synthesis using enzymatic activation and coupling
Grant 8,883,444 - Quaedflieg , et al. November 11, 2
2014-11-11
Chemo-enzymatic peptide synthesis via C-terminal ester interconversion
Grant 8,450,084 - Quaedflieg , et al. May 28, 2
2013-05-28
Peptide Synthesis Using Enzymatic Activation An Coupling
App 20120129214 - Quaedflieg; Peter Jan Leonard Mario ;   et al.
2012-05-24
Chemo-enzymatic Peptide Synthesis Via C-terminal Ester Interconversion
App 20100311113 - Quaedflieg; Peter Jan Leonard Mario ;   et al.
2010-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed